133 related articles for article (PubMed ID: 3411968)
1. Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasia.
Koo HB; Sigurdson ER; Daly JM; Berenson M; Groshen S; Decosse JJ
J Surg Oncol; 1988 Aug; 38(4):240-3. PubMed ID: 3411968
[TBL] [Abstract][Full Text] [Related]
2. [A study of ornithine decarboxylase activity in tumor tissue and rectal mucosa in patients with colorectal cancer or adenoma].
Murakami S; Haruma K; Sumii K; Tari A; Yoshihara M; Inoue K; Kimura M; Matsubara H; Teshima H; Tokumo K
Nihon Shokakibyo Gakkai Zasshi; 1989 Jun; 86(6):1260-5. PubMed ID: 2795955
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ornithine decarboxylase activity in rectal mucosa as a marker for colorectal adenomas and carcinomas.
Moorehead RJ; Hoper M; McKelvey ST
Br J Surg; 1987 May; 74(5):364-5. PubMed ID: 3594125
[TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
5. Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia.
Sandler RS; Ulshen MH; Lyles CM; McAuliffe CA; Fuller CR
Dig Dis Sci; 1992 Nov; 37(11):1718-24. PubMed ID: 1425072
[TBL] [Abstract][Full Text] [Related]
6. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.
Nishioka K; Grossie VB; Chang TH; Ajani JA; Ota DM
J Surg Oncol; 1991 Jun; 47(2):117-20. PubMed ID: 2062082
[TBL] [Abstract][Full Text] [Related]
7. Increased mucosal ornithine decarboxylase activity in large bowel with multiple tumors, adenocarcinoma, and adenoma.
Narisawa T; Takahashi M; Niwa M; Koyama H; Kotanagi H; Kusaka N; Yamazaki Y; Nagasawa O; Koyama K; Wakizaka A
Cancer; 1989 Apr; 63(8):1572-6. PubMed ID: 2924264
[TBL] [Abstract][Full Text] [Related]
8. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.
Braverman DZ; Stankiewicz H; Goldstein R; Patz JK; Morali GA; Jacobsohn WZ
Am J Gastroenterol; 1990 Jun; 85(6):723-6. PubMed ID: 2353692
[TBL] [Abstract][Full Text] [Related]
9. Relationship of ornithine decarboxylase activity and human colon tumorigenesis.
Takami H; Koudaira H; Kodaira S
Jpn J Clin Oncol; 1994 Jun; 24(3):141-3. PubMed ID: 8007423
[TBL] [Abstract][Full Text] [Related]
10. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa.
Linsalata M; Russo F; Cavallini A; Berloco P; Di Leo A
Dis Colon Rectum; 1993 Jul; 36(7):662-7. PubMed ID: 8348850
[TBL] [Abstract][Full Text] [Related]
11. Colon ornithine decarboxylase activity following standard endoscopy preparation regimens.
Love RR; Verma AK; Surawicz TS; Morrissey JF
J Surg Oncol; 1989 Nov; 42(3):150-3. PubMed ID: 2554065
[TBL] [Abstract][Full Text] [Related]
12. Absence of effect of supplemental oral calcium on ornithine decarboxylase (ODC) activity in colonic mucosae of healthy individuals with a family history of colorectal cancer.
Love RR; Verma AK; Surawicz TS; Morrissey JF
J Surg Oncol; 1990 Feb; 43(2):79-82. PubMed ID: 2304344
[TBL] [Abstract][Full Text] [Related]
13. High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia.
LaMuraglia GM; Lacaine F; Malt RA
Ann Surg; 1986 Jul; 204(1):89-93. PubMed ID: 3729588
[TBL] [Abstract][Full Text] [Related]
14. Failure of rectal ornithine decarboxylase to identify adenomatous polyp status.
Desai TK; Parikh N; Bronstein JC; Luk GD; Bull AW
Gastroenterology; 1992 Nov; 103(5):1562-7. PubMed ID: 1426875
[TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase assay in human colorectal mucosa. Methodologic issues of importance to quality control.
Garewal HS; Sloan D; Sampliner RE; Fennerty B
Int J Cancer; 1992 Sep; 52(3):355-8. PubMed ID: 1399110
[TBL] [Abstract][Full Text] [Related]
16. Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features.
Allgayer H; Roisch U; Zehnter E; Ziegenhagen DJ; Dienes HP; Kruis W
Dig Dis Sci; 2007 Jan; 52(1):25-30. PubMed ID: 17171446
[TBL] [Abstract][Full Text] [Related]
17. beta-Carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients.
Phillips RW; Kikendall JW; Luk GD; Willis SM; Murphy JR; Maydonovitch C; Bowen PE; Stacewicz-Sapuntzakis M; Wong RK
Cancer Res; 1993 Aug; 53(16):3723-5. PubMed ID: 8339282
[TBL] [Abstract][Full Text] [Related]
18. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
Matsubara N; Hietala OA; Gilmour SK; Yum KY; Litwin S; Watts P; Brennan ; O'Brien
Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
Luk GD; Moshier JA; Ehrinpreis MN
Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]